Literature DB >> 4082237

New and simple method to predict dosage of drugs obeying simple Michaelis-Menten elimination kinetics and to distinguish such kinetics from simple first order and from parallel Michaelis-Menten and first order kinetics.

J G Wagner.   

Abstract

It has been found empirically that either average or minimum steady-state plasma concentrations (Css) of drugs obeying Michaelis-Menten elimination kinetics give essentially linear plots on semilogarithmic graph paper when Css is plotted versus the maintenance dose (D) or dose rate (R). The equations of such straight lines may be converted to the following nonlinear equation: Css = abD which fits the Css,D data essentially as well as D = VmCss/(Km + Css). The parameter b is analogous to unity plus the interest fraction in logarithmic growth or compound interest calculations, and each drug appears to have a characteristic value of this parameter, with extremely small intersubject variation. From the above equation the following equation, Dn+1 = Dn + 1n(Cn+1/Cn)1n b can be derived, which forms the basis of predicting the needed dosage, Dn+1, to obtain a desired steady-state concentration, Cn+1, using one initial steady-state concentration, Cn, obtained with dose, Dn, and using a population value of b for the drug. It appears that it is the value of the "initial capital" (i.e., a in relation to the initial dose) rather than the "interest fraction" (i.e., b - 1) that causes most of the intersubject variation in Css of a given drug. Several drugs illustrate the usefulness of the method. A semilogarithmic plot also appears to be an excellent method to distinguish simple Michaelis-Menten kinetics from parallel Michaelis-Menten and first order elimination kinetics and from simple first order kinetics with steady-state data in the range 0.3-3 Km.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4082237     DOI: 10.1097/00007691-198512000-00003

Source DB:  PubMed          Journal:  Ther Drug Monit        ISSN: 0163-4356            Impact factor:   3.681


  6 in total

Review 1.  Therapeutic drug monitoring of phenytoin. Rationale and current status.

Authors:  M Levine; T Chang
Journal:  Clin Pharmacokinet       Date:  1990-11       Impact factor: 6.447

Review 2.  Bayesian parameter estimation and population pharmacokinetics.

Authors:  A H Thomson; B Whiting
Journal:  Clin Pharmacokinet       Date:  1992-06       Impact factor: 6.447

Review 3.  Optimisation of antiepileptic drug therapy. The importance of serum drug concentration monitoring.

Authors:  E Yukawa
Journal:  Clin Pharmacokinet       Date:  1996-08       Impact factor: 6.447

Review 4.  An updated comparison of drug dosing methods. Part I: Phenytoin.

Authors:  R D Pryka; K A Rodvold; S M Erdman
Journal:  Clin Pharmacokinet       Date:  1991-03       Impact factor: 6.447

Review 5.  Pharmacokinetic optimisation of anticonvulsant therapy.

Authors:  A H Thomson; M J Brodie
Journal:  Clin Pharmacokinet       Date:  1992-09       Impact factor: 6.447

6.  Computational identification, characterization and validation of potential antigenic peptide vaccines from hrHPVs E6 proteins using immunoinformatics and computational systems biology approaches.

Authors:  Abbas Khan; Muhammad Junaid; Aman Chandra Kaushik; Arif Ali; Syed Shujait Ali; Aamir Mehmood; Dong-Qing Wei
Journal:  PLoS One       Date:  2018-05-01       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.